| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Tumor Biology |
Department of Oncology, Jubileum Institute, University Hospital, S-221 85 Lund, Sweden [K. R., B. B., M. T., J. I.]; Institute of Medical Technology, Tampere University and University Hospital, Tampere, FIN-33101 Finland [S. K., M. T., J. I.]; and Department of Molecular Medicine, Karolinska Hospital, CMML 8:01, Stockholm, S-17176 Sweden [S. K.]
Breast carcinoma is thought to arise because of multiple successive changes in the genome of the normal epithelial cells. However, little is known of the order of appearance of different types of genetic aberrations. We studied the ERBB2 (Her-2/neu) and CCND1 (cyclin D1) oncogene amplification in flow cytometrically sorted diploid and nondiploid tumor cell populations by fluorescence in situ hybridization (FISH). The purity of the cell sorting was confirmed by static DNA image cytometry. Spectral karyotyping was used to define differences in a genome-wide manner between two distinctly different aneuploid cell clones found in each of two breast cancer cell lines. FISH indicated the presence of gene amplification both in diploid and nondiploid cell clones in 17 of the 21 amplification-containing tumors analyzed. The oncogene copy numbers remained unchanged throughout aneuploidization in 11 of 17 tumors. The remaining six tumors showed an increase in oncogene copy number as well as the number of chromosome 11 or 17 centromeres (the original location of CCND1 and ERBB2, respectively). Breast carcinoma cell lines MDA-157 and MDA-436 showed a significant number of chromosomal rearrangements in the near-diploid clones, which were present in duplicate in the corresponding aneuploid (polyploid) clones. These results indicate that ploidy shift, i.e., aneuploidization, in breast cancer is a late genetic event, which is preceded by both oncogene amplifications as well as many chromosomal rearrangements.
This article has been cited by other articles:
![]() |
L. Melchor, S. Alvarez, E. Honrado, J. Palacios, A. Barroso, O. Diez, A. Osorio, and J. Benitez The Accumulation of Specific Amplifications Characterizes Two Different Genomic Pathways of Evolution of Familial Breast Tumors Clin. Cancer Res., December 15, 2005; 11(24): 8577 - 8584. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Yamaura, M. Takata, A. Miyazaki, and T. Saida Specific Dermoscopy Patterns and Amplifications of the Cyclin D1 Gene to Define Histopathologically Unrecognizable Early Lesions of Acral Melanoma In Situ Arch Dermatol, November 1, 2005; 141(11): 1413 - 1418. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Arnold and A. Papanikolaou Cyclin D1 in Breast Cancer Pathogenesis J. Clin. Oncol., June 20, 2005; 23(18): 4215 - 4224. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-Y. Hwang, S. Smith, and K. Myung The Rad1-Rad10 Complex Promotes the Production of Gross Chromosomal Rearrangements From Spontaneous DNA Damage in Saccharomyces cerevisiae Genetics, April 1, 2005; 169(4): 1927 - 1937. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. J. Nelsen, R. Kuriyama, B. Hirsch, V. C. Negron, W. L. Lingle, M. M. Goggin, M. W. Stanley, and J. H. Albrecht Short Term Cyclin D1 Overexpression Induces Centrosome Amplification, Mitotic Spindle Abnormalities, and Aneuploidy J. Biol. Chem., January 7, 2005; 280(1): 768 - 776. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Banerjee and K. Myung Increased Genome Instability and Telomere Length in the elg1-Deficient Saccharomyces cerevisiae Mutant Are Regulated by S-Phase Checkpoints Eukaryot. Cell, December 1, 2004; 3(6): 1557 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Rennstam, M. Ahlstedt-Soini, B. Baldetorp, P.-O. Bendahl, A. Borg, R. Karhu, M. Tanner, M. Tirkkonen, and J. Isola Patterns of Chromosomal Imbalances Defines Subgroups of Breast Cancer with Distinct Clinical Features and Prognosis. A Study of 305 Tumors by Comparative Genomic Hybridization Cancer Res., December 15, 2003; 63(24): 8861 - 8868. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Staff, J. Isola, and M. Tanner Haplo-insufficiency of BRCA1 in Sporadic Breast Cancer Cancer Res., August 15, 2003; 63(16): 4978 - 4983. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. S. Larson, A. de las Morenas, S. R. Bennett, L. A. Cupples, and C. L. Rosenberg Loss of Heterozygosity or Allele Imbalance in Histologically Normal Breast Epithelium Is Distinct from Loss of Heterozygosity or Allele Imbalance in Co-Existing Carcinomas Am. J. Pathol., July 1, 2002; 161(1): 283 - 290. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tanner, P. Jarvinen, and J. Isola Amplification of HER-2/neu and Topoisomerase II{alpha} in Primary and Metastatic Breast Cancer Cancer Res., July 1, 2001; 61(14): 5345 - 5348. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. L. Lingle, S. L. Barrett, V. C. Negron, A. B. D'Assoro, K. Boeneman, W. Liu, C. M. Whitehead, C. Reynolds, and J. L. Salisbury Centrosome amplification drives chromosomal instability in breast tumor development PNAS, February 19, 2002; 99(4): 1978 - 1983. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |